Extended dose intervals for COVID-19 vaccines to optimize early vaccine rollout and population protection in Canada in the context of limited vaccine supply

You're currently viewing an old version of this dataset. Some resources may no longer exist or the dataset may not display correctly. To see the current version, click here.

Since COVID-19 vaccines were first authorized in Canada in December 2020, the National Advisory Committee on Immunization (NACI) has been providing evidence-informed guidance on the recommended interval between vaccine doses.

Data and Resources

Similar records